Effect of methamphetamine on rat primary midbrain cells; mitochondrial biogenesis as a compensatory response

Area of Science:

• Neuroscience
• Toxicology
• Cell Biology

Background:

• Methamphetamine (MA) is a neurotoxic drug known to induce cell death through mechanisms like mitochondrial dysfunction.
• Understanding MA's impact on neuronal and glial cells is crucial for addressing its neurodegenerative potential.

Purpose of the Study:

• To investigate the effects of varying methamphetamine concentrations on cell viability and mitochondrial biogenesis in primary midbrain cultures.
• To assess the impact of MA on neuronal and glial markers and the expression of key mitochondrial biogenesis factors.

Main Methods:

• Primary mesencephalon cells from E14.5 rat embryos were exposed to 0.2-5 mM MA for 24, 48, or 72 hours.
• Cell viability was assessed using MTT assays, and cell death was evaluated via immunocytochemistry.
• Gene expression of mitochondrial biogenesis factors (PGC1α, NRF1, TFAM) and cell markers (neuronal, glial) was quantified using qPCR.

Main Results:

• Low to moderate MA concentrations (e.g., 1 mM) increased cell viability, while higher concentrations (e.g., 5 mM) and longer exposure times decreased it, causing morphological damage.
• High MA concentrations (5 mM) reduced the number and mRNA levels of neuronal (β3-tubulin, TH) and glial (GFAP, Iba1) markers.
• Unexpectedly, gene expression of mitochondrial biogenesis factors (PGC1α, NRF1, TFAM) increased at 5 mM MA, suggesting a compensatory response.

Conclusions:

• Methamphetamine exerts dose-dependent effects on midbrain cell viability, with moderate doses potentially enhancing survival and high doses inducing cell death.
• Despite the activation of mitochondrial biogenesis pathways at high MA concentrations, this compensatory mechanism failed to prevent neuronal and glial cell death.
• These findings highlight the complex neurotoxic mechanisms of MA and the limitations of compensatory pathways in mitigating its damaging effects.